Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Biotoscana Investments S.A. (B3: GBIO33), a biopharmaceutical group that operates in Latin America, announced today its results for the 3Q18 and 9M18....
Biotoscana Investments S.A. (B3: GBIO33), um grupo biofarmacêutico que opera na América Latina, anuncia hoje seus resultados para o 2T18. DESTAQUES A ...
Biotoscana Investments S.A. (B3: GBIO33), a biopharmaceutical group that operates in Latin America, announced today its results for the 2Q18....
O Biotoscana Investments S.A. (B3: GBIO33), um grupo biofarmacêutico que opera na América Latina, anuncia hoje seus resultados para o 1T18. DESTAQUES ...
Biotoscana Investments S.A. (B3: GBIO33), a biopharmaceutical group that operates in Latin America, announced today its results for the 1Q18....
Biotoscana Investments S.A. (B3: GBIO33), a biopharmaceutical group that operates in Latin America, announced today its results for the 4Q17 and full ...
BIOTOSCANA INVESTMENTS S.A. ("Company" or "GBT") (B3: GBIO33), a leading biopharmaceutical company in Latin America, announces to its shareholders...
MONTEVIDEO, Uruguay, Nov. 13, 2017 GBT-Grupo Biotoscana (B3: GBIO33), a leading biopharmaceutical company in Latin America, today announced the...
GBT-Grupo Biotoscana (B3: GBIO33), a leading biopharmaceutical company in Latin America, today announced that Advent International, a key...
GBT-Grupo Biotoscana (B3: GBIO33), a leading biopharmaceutical company in Latin America, today announced a realignment of its management structure to ...
GBT- Grupo Biotoscana (B3: GBIO33), uma empresa biofarmacêutica líder na América Latina, anunciou hoje que assinou um acordo de licenciamento...
GBT-Grupo Biotoscana (B3: GBIO33), la primera empresa biofarmacéutica en América Latina, anunció hoy que ha firmado un acuerdo de licencia exclusiva...
GBT- Grupo Biotoscana (B3: GBIO33), a leading biopharmaceutical company in Latin America, today announced that it has entered into an exclusive...
El Grupo Biotoscana SL (GBT), compañía biofarmacéutica de especialidad líder en el mercado latinoamericano, anunció hoy que ha completado un acuerdo...
El Grupo Biotoscana SL (GBT), compañía farmacéutica de especialidades líder en Latinoamérica, anunció en el día de la fecha su continuo progreso en...
Grupo Biotoscana SL, una compañía farmacéutica de especialidades líder en Latinoamérica, anunció hoy que ha completado la adquisición de Laboratorio...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.